Search results
- Regulatory news (469) Apply Regulatory news filter
- Press releases (231) Apply Press releases filter
- Basic page (60) Apply Basic page filter
- Corporate presentations (26) Apply Corporate presentations filter
- Pipeline (26) Apply Pipeline filter
- Shareholder meeting (24) Apply Shareholder meeting filter
- Team member (22) Apply Team member filter
- Videos (16) Apply Videos filter
- Financial reports (12) Apply Financial reports filter
- Webcasts and audio (12) Apply Webcasts and audio filter
- Analyst (11) Apply Analyst filter
- Investor contact (6) Apply Investor contact filter
- Event (4) Apply Event filter
- Research (3) Apply Research filter
- Financial calendar (1) Apply Financial calendar filter
- Webform (1) Apply Webform filter
Oxford Biomedica notes announcement that FDA has lifted clinical hold on Homology Medicines’ pheNIX trial
Oxford, UK – 14 June 2022: Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Company”), a leading gene and cell therapy g
Oxford Biomedica signs new three year agreement with AstraZeneca
The information contained within this announcement is deemed by the Group to constitute inside information as stipulated under the Market Abuse